Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Aryl Hydrocarbon Receptor Gene Silencing with Small Inhibitory RNA Differentially Modulates Ah-Responsiveness in MCF-7 and HepG2 Cancer Cells

Maen Abdelrahim, Roger Smith III and Stephen Safe
Molecular Pharmacology June 2003, 63 (6) 1373-1381; DOI: https://doi.org/10.1124/mol.63.6.1373
Maen Abdelrahim
Departments of Veterinary Physiology and Pharmacology (M.A., S.S.) and Veterinary Pathobiology (R.S.), Texas A&M University, College Station, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Smith III
Departments of Veterinary Physiology and Pharmacology (M.A., S.S.) and Veterinary Pathobiology (R.S.), Texas A&M University, College Station, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Safe
Departments of Veterinary Physiology and Pharmacology (M.A., S.S.) and Veterinary Pathobiology (R.S.), Texas A&M University, College Station, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 63 no. 6 1373-1381
DOI 
https://doi.org/10.1124/mol.63.6.1373
PubMed 
12761348

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received November 8, 2002
  • Accepted March 7, 2003
  • Published online June 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Maen Abdelrahim,
  2. Roger Smith III, and
  3. Stephen Safe
  1. Departments of Veterinary Physiology and Pharmacology (M.A., S.S.) and Veterinary Pathobiology (R.S.), Texas A&M University, College Station, Texas
  1. Address correspondence to:
    Stephen Safe, Department of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, Veterinary Research Building 409, College Station, TX 77843-4466. E-mail: ssafe{at}cvm.tamu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2003 to May 2022

AbstractFullPdf
May 200344186155
Jun 200331280171
Jul 200332203140
Aug 20032314377
Sep 20032312189
Oct 20032013272
Nov 2003247930
Dec 2003268739
Jan 20042010469
Feb 2004167348
Mar 2004148243
Apr 200495323
May 2004157244
Jun 2004236754
Jul 2004325639
Aug 2004224736
Sep 2004136537
Oct 2004197025
Nov 2004159353
Dec 2004229627
Jan 2005227546
Feb 2005195026
Mar 2005176836
Apr 2005154227
May 200594625
Jun 2005103322
Jul 2005164326
Aug 200595130
Sep 2005363530
Oct 2005705233
Nov 2005203730
Dec 200543830
Jan 2006184526
Feb 200693116
Mar 200673717
Apr 2006103422
May 200654122
Jun 200643123
Jul 200693215
Aug 2006122920
Sep 2006111319
Oct 2006143123
Nov 200673615
Dec 200692715
Jan 200732222
Feb 200773023
Mar 2007122823
Apr 2007123323
May 200772112
Jun 200752114
Jul 200762513
Aug 20078237
Sep 200741815
Oct 2007145331
Nov 200772917
Dec 200792419
Jan 2008101312
Feb 2008211923
Mar 2008122317
Apr 2008182012
May 2008121613
Jun 2008183321
Jul 2008282016
Aug 2008322515
Sep 2008283214
Oct 200812219
Nov 2008173320
Dec 2008151612
Jan 200982317
Feb 2009132914
Mar 2009182215
Apr 200912135
May 200991612
Jun 20099119
Jul 2009172820
Aug 200951711
Sep 2009889
Oct 2009121715
Nov 2009101213
Dec 20099215
Jan 20101056
Feb 201017613
Mar 20101398
Apr 201011169
May 2010102012
Jun 2010213012
Jul 2010111310
Aug 2010989
Sep 201013166
Oct 2010181610
Nov 201082015
Dec 201010157
Jan 2011131914
Feb 2011434214
Mar 201131139
Apr 2011151115
May 2011211314
Jun 2011141120
Jul 2011181126
Aug 2011161020
Sep 201118159
Oct 201113249
Nov 2011151622
Dec 2011112016
Jan 2012162422
Feb 2012194038
Mar 2012214427
Apr 2012184427
May 2012132623
Jun 2012121525
Jul 2012132026
Aug 201215179
Sep 2012122528
Oct 2012112920
Nov 2012162624
Dec 2012172524
Jan 2013183826
Feb 201371914
Mar 2013293414
Apr 2013331522
May 2013191922
Jun 201372018
Jul 201352111
Aug 201366837
Sep 2013132713
Oct 2013191618
Nov 201327329
Dec 2013121912
Jan 2014261614
Feb 2014191319
Mar 20147179
Apr 2014111613
May 2014162314
Jun 2014202215
Jul 2014134029
Aug 201441710
Sep 20141196
Oct 201413185
Nov 201419187
Dec 2014123011
Jan 20157166
Feb 2015222611
Mar 2015141411
Apr 20151187
May 20159176
Jun 201573710
Jul 2015152514
Aug 201512216
Sep 201518169
Oct 201592012
Nov 2015111515
Dec 201518139
Jan 2016252114
Feb 2016472022
Mar 2016412318
Apr 20163699
May 2016292022
Jun 2016181110
Jul 2016191314
Aug 201620108
Sep 201637168
Oct 201617276
Nov 2016171210
Dec 201642410
Jan 20171485
Feb 20170287
Mar 20176234
Apr 20175224
May 201731810
Jun 201743710
Jul 201722212
Aug 20172242
Sep 201722212
Oct 201722912
Nov 201713115
Dec 20173318
Jan 201861710
Feb 20183138
Mar 20186129
Apr 201833115
May 201801512
Jun 20182218
Jul 20181184
Aug 201831112
Sep 201822016
Oct 201821812
Nov 201823015
Dec 20181834
Jan 20191786
Feb 20193063
Mar 201937108
Apr 20192764
May 20191423
Jun 20191533
Jul 201928105
Aug 20192934
Sep 20191652
Oct 20192035
Nov 20193154
Dec 20192501
Jan 20203153
Feb 20202301
Mar 20201001
Apr 20201300
May 20201820
Jun 20202921
Jul 20203300
Aug 20201801
Sep 20202230
Oct 20202100
Nov 20201700
Dec 20201501
Jan 202116102
Feb 20211292
Mar 20212431
Apr 20211530
May 20213342
Jun 20213092
Jul 20211653
Aug 20211471
Sep 20211574
Oct 20214530
Nov 20213834
Dec 20212210
Jan 20223962
Feb 20222463
Mar 20221354
Apr 20223422
May 2022842

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 63 (6)
Molecular Pharmacology
Vol. 63, Issue 6
1 Jun 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Aryl Hydrocarbon Receptor Gene Silencing with Small Inhibitory RNA Differentially Modulates Ah-Responsiveness in MCF-7 and HepG2 Cancer Cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Aryl Hydrocarbon Receptor Gene Silencing with Small Inhibitory RNA Differentially Modulates Ah-Responsiveness in MCF-7 and HepG2 Cancer Cells

Maen Abdelrahim, Roger Smith and Stephen Safe
Molecular Pharmacology June 1, 2003, 63 (6) 1373-1381; DOI: https://doi.org/10.1124/mol.63.6.1373

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Aryl Hydrocarbon Receptor Gene Silencing with Small Inhibitory RNA Differentially Modulates Ah-Responsiveness in MCF-7 and HepG2 Cancer Cells

Maen Abdelrahim, Roger Smith and Stephen Safe
Molecular Pharmacology June 1, 2003, 63 (6) 1373-1381; DOI: https://doi.org/10.1124/mol.63.6.1373
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
  • Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics